Prescient Therapeutics Limited (ASX:PTX)

Prescient Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	9.75	6.91	10.49	5.9	12.26	16.1
Short-Term Investments	0.02	0.02	4.02	16.02	0.02	0.02
Cash & Short-Term Investments	9.77	6.93	14.51	21.92	12.28	16.12
Cash Growth	41.03%	-52.27%	-33.78%	78.41%	-23.79%	118.48%
Accounts Receivable	5.7	4.91	3.92	2.58	1.72	1.24
Receivables	5.7	4.91	3.92	2.58	1.72	1.24
Prepaid Expenses	1.09	1.06	0.31	0.25	0.24	0.24
Total Current Assets	16.56	12.9	18.74	24.74	14.25	17.6
Property, Plant & Equipment	0.27	0.01	0	0	0	0
Other Intangible Assets	1.65	1.65	1.65	3.37	3.37	3.37
Total Assets	18.48	14.56	20.39	28.11	17.62	20.97

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	1.13	3.04	1.72	1.78	0.51	0.23
Accrued Expenses	0.1	0.07	0.22	0.2	0.12	0.07
Short-Term Debt	-	-	0.33	-	-	0.17
Other Current Liabilities	-	0.05	0.05	0.05	0.18	0.04
Total Current Liabilities	1.28	3.16	2.32	2.03	0.81	0.51
Pension & Post-Retirement Benefits	0.01	0.01	0.01	0.01	0.05	0.03
Total Liabilities	1.51	3.17	2.33	2.03	0.86	0.54

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	102.79	93.89	93.27	93.25	77.26	76.67
Retained Earnings	-87.53	-84.07	-77.4	-69.31	-62.45	-57.51
Comprehensive Income & Other	1.71	1.57	2.19	2.14	1.95	1.26
Shareholders' Equity	16.97	11.39	18.07	26.08	16.76	20.43
Total Liabilities & Equity	18.48	14.56	20.39	28.11	17.62	20.97

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	0.27	-	0.33	-	-	0.17
Net Cash (Debt)	9.5	6.93	14.18	21.92	12.28	15.95
Net Cash Growth	37.09%	-51.16%	-35.28%	78.41%	-22.99%	120.93%
Net Cash Per Share	0.01	0.01	0.02	0.03	0.02	0.03
Filing Date Shares Outstanding	1,052	805.32	805.32	805.27	654.32	641.05
Total Common Shares Outstanding	1,052	805.32	805.32	805.27	654.32	641.05
Working Capital	15.28	9.74	16.42	22.71	13.44	17.08
Book Value Per Share	0.02	0.01	0.02	0.03	0.03	0.03
Tangible Book Value	15.32	9.74	16.42	22.71	13.4	17.06
Tangible Book Value Per Share	0.01	0.01	0.02	0.03	0.02	0.03

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 31, 2026

Data Sources Report a data error